Use of heat-shock protein 27 for cardiovascular disease prevention and treatment
US8343915B2 · kind B2 · utility
0Cited by
0References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 11, 2008 |
| Grant date | Jan 1, 2013 |
| Priority date | — |
| Expiry date | Sep 24, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of preventing or treating cardiovascular disease is provided. The method comprises administering heat shock protein 27 (HSP27), a co-factor, variant or analogue thereof. The cardiovascular disease can include atherosclerosis. A pharmaceutical composition comprising HSP27 for use in the prevention or treatment of cardiovascular disease is also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.